314 related articles for article (PubMed ID: 16616187)
21. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
22. Immunolocalization of VEGF, VEGFR-1 and VEGFR-2 in lung tissues after acute hemorrhage in rats.
Ekerbicer N; Tarakci F; Barut T; Inan S
Acta Histochem; 2008; 110(4):285-93. PubMed ID: 18321563
[TBL] [Abstract][Full Text] [Related]
23. The biology of vascular endothelial growth factor-B (VEGF-B).
Nash AD; Baca M; Wright C; Scotney PD
Pulm Pharmacol Ther; 2006; 19(1):61-9. PubMed ID: 16286239
[TBL] [Abstract][Full Text] [Related]
24. VEGF receptor protein-tyrosine kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2008 Oct; 375(3):287-91. PubMed ID: 18680722
[TBL] [Abstract][Full Text] [Related]
25. Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy.
Kaczmarek MM; Kowalczyk AE; Waclawik A; Schams D; Ziecik AJ
Mol Reprod Dev; 2007 Jun; 74(6):730-9. PubMed ID: 17120307
[TBL] [Abstract][Full Text] [Related]
26. Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors.
Zhang J; Li H; Chen W; Cao P; Wang M
Biotechnol Prog; 2009; 25(6):1703-8. PubMed ID: 19731341
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.
Shibuya M; Claesson-Welsh L
Exp Cell Res; 2006 Mar; 312(5):549-60. PubMed ID: 16336962
[TBL] [Abstract][Full Text] [Related]
28. Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity.
Iyer S; Darley PI; Acharya KR
J Biol Chem; 2010 Jul; 285(31):23779-89. PubMed ID: 20501651
[TBL] [Abstract][Full Text] [Related]
29. VEGFR-3 in adult angiogenesis.
Witmer AN; van Blijswijk BC; Dai J; Hofman P; Partanen TA; Vrensen GF; Schlingemann RO
J Pathol; 2001 Nov; 195(4):490-7. PubMed ID: 11745682
[TBL] [Abstract][Full Text] [Related]
30. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma.
Ebos JM; Bocci G; Man S; Thorpe PE; Hicklin DJ; Zhou D; Jia X; Kerbel RS
Mol Cancer Res; 2004 Jun; 2(6):315-26. PubMed ID: 15235107
[TBL] [Abstract][Full Text] [Related]
31. Structural determinants of growth factor binding and specificity by VEGF receptor 2.
Leppänen VM; Prota AE; Jeltsch M; Anisimov A; Kalkkinen N; Strandin T; Lankinen H; Goldman A; Ballmer-Hofer K; Alitalo K
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2425-30. PubMed ID: 20145116
[TBL] [Abstract][Full Text] [Related]
32. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
Gaumann A; Groot M; Drexler HC; Breier G
Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor in chronic rat allograft nephropathy.
Malmström NK; Kallio EA; Rintala JM; Nykänen AI; Räisänen-Sokolowski AK; Paavonen T; Lemström KB; Koskinen PK
Transpl Immunol; 2008 May; 19(2):136-44. PubMed ID: 18503889
[TBL] [Abstract][Full Text] [Related]
34. Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro.
Mould AW; Greco SA; Cahill MM; Tonks ID; Bellomo D; Patterson C; Zournazi A; Nash A; Scotney P; Hayward NK; Kay GF
Circ Res; 2005 Sep; 97(6):e60-70. PubMed ID: 16109918
[TBL] [Abstract][Full Text] [Related]
35. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.
Heil M; Mitnacht-Krauss R; Issbrücker K; van den Heuvel J; Dehio C; Schaper W; Clauss M; Weich HA
Angiogenesis; 2003; 6(3):201-11. PubMed ID: 15041796
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
Mylona E; Alexandrou P; Giannopoulou I; Liapis G; Sofia M; Keramopoulos A; Nakopoulou L
Gynecol Oncol; 2007 Mar; 104(3):557-63. PubMed ID: 17150246
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
39. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway.
Vogel C; Bauer A; Wiesnet M; Preissner KT; Schaper W; Marti HH; Fischer S
J Cell Physiol; 2007 Jul; 212(1):236-43. PubMed ID: 17311300
[TBL] [Abstract][Full Text] [Related]
40. Localization of vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 and VEGFR-2 in bovine placentomes from implantation until term.
Pfarrer CD; Ruziwa SD; Winther H; Callesen H; Leiser R; Schams D; Dantzer V
Placenta; 2006 Aug; 27(8):889-98. PubMed ID: 16263165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]